trending Market Intelligence /marketintelligence/en/news-insights/trending/u39xbrqq78acoun872z3ia2 content esgSubNav
In This List

Dova Pharmaceuticals plans common stock offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Dova Pharmaceuticals plans common stock offering

Dova Pharmaceuticals Inc. plans to sell 2.5 million of its common shares in an underwritten public offering.

The company also plans grant the underwriters an option to buy up to an additional 375,000 common shares.

J.P. Morgan Securities LLC, Jefferies LLC and Evercore Group LLC are serving as joint book-running managers for the offering.